MX2021014518A - Composicion nutricional. - Google Patents

Composicion nutricional.

Info

Publication number
MX2021014518A
MX2021014518A MX2021014518A MX2021014518A MX2021014518A MX 2021014518 A MX2021014518 A MX 2021014518A MX 2021014518 A MX2021014518 A MX 2021014518A MX 2021014518 A MX2021014518 A MX 2021014518A MX 2021014518 A MX2021014518 A MX 2021014518A
Authority
MX
Mexico
Prior art keywords
nutritional composition
protein
composition
grams
npn
Prior art date
Application number
MX2021014518A
Other languages
English (en)
Inventor
Christina Josephina Antonia Maria Timmer-Keetels
Thom Huppertz
Roelof Bos
Jeroen Margot Leon Heck
Original Assignee
Frieslandcampina Nederland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frieslandcampina Nederland Bv filed Critical Frieslandcampina Nederland Bv
Publication of MX2021014518A publication Critical patent/MX2021014518A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Mycology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)

Abstract

La invención se refiere a una composición nutricional que comprende hidratos de carbono, proteína y una composición de grasa, en la que: (a) la composición nutricional tiene un contenido de calcio total en materia seca de al menos 3.5 g/kg; (b) la proteína comprende caseína; (c) la composición nutricional tiene un contenido de calcio unido a proteína de 7.5 mmoles o menos por 10 gramos de caseína; y (d) la proporción de NPN con respecto a TN es de 0.7 o menos: - significando NPN nitrógeno no proteico en la composición nutricional en gramos por 100 gramos de composición nutricional (g/100 g); y - significando TN nitrógeno total (TN) en la composición nutricional en g/100 g. La invención se refiere además a un procedimiento para la preparación de la composición nutricional en forma de polvo y a la composición para su uso en la prevención del malestar intestinal y el estreñimiento en sujetos humanos, en particular sujetos humanos de 0 a 36 meses de edad.
MX2021014518A 2019-05-27 2020-05-26 Composicion nutricional. MX2021014518A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19176789 2019-05-27
PCT/EP2020/064498 WO2020239722A1 (en) 2019-05-27 2020-05-26 Nutritional composition

Publications (1)

Publication Number Publication Date
MX2021014518A true MX2021014518A (es) 2022-01-06

Family

ID=66676222

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014518A MX2021014518A (es) 2019-05-27 2020-05-26 Composicion nutricional.

Country Status (7)

Country Link
US (1) US20220211763A1 (es)
EP (1) EP3975729A1 (es)
CN (1) CN113873888A (es)
MX (1) MX2021014518A (es)
SG (1) SG11202111944SA (es)
TW (1) TW202110332A (es)
WO (1) WO2020239722A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220079962A1 (en) 2019-06-04 2022-03-17 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and dietary butyrate
CN116973435B (zh) * 2023-09-22 2023-12-22 北京三元食品股份有限公司 一种母乳矿物元素的评估方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH313363A (de) * 1951-10-22 1956-04-15 Heinz Dr Med Lemke Verfahren zur Herstellung eines leicht verdaulichen Trinkmilchpräparates
CH340404A (de) * 1955-03-08 1959-08-15 Hipp Werk Georg Hipp Verfahren zur Herstellung von Säuglingsnahrung
CH398281A (de) * 1961-06-28 1965-08-31 Nestle Sa Verfahren zur Herstellung einer Säuglingsmilch in Pulverform
CH600787A5 (es) * 1975-03-20 1978-06-30 Nestle Sa
JP3437358B2 (ja) * 1995-12-05 2003-08-18 雪印乳業株式会社 ミネラル補強用組成物及びその製造方法
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
RU2184457C1 (ru) * 2000-12-19 2002-07-10 Государственное научное учреждение Научно-исследовательский институт детского питания РАСХН Композиция для приготовления кисломолочного продукта для детского и диетического питания
US7651716B2 (en) * 2001-12-21 2010-01-26 Wyeth Llc Methods for reducing adverse effects of feeding formula to infants
NZ552352A (en) * 2006-12-22 2009-07-31 Fonterra Co Operative Group Dairy product produced from milk protein isolate or milk protein concentrate with reduced calcium and phosphate ion concentrations
IE20080476A1 (en) * 2008-06-10 2010-03-03 Teagasc Miscellar casein powders with different levels of calcium and cheeses prepared therefrom
US9282755B2 (en) * 2008-09-02 2016-03-15 Intercontinental Great Brands Llc Heat stable concentrated dairy liquid and cream product
MX355780B (es) * 2010-12-31 2018-04-30 Abbott Lab Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.
CN102415447B (zh) * 2011-12-06 2013-07-24 汉臣氏（沈阳）儿童制品有限公司 一种适用于婴幼儿的补钙冲剂及其制备工艺
EP2861080B1 (en) * 2012-06-15 2017-04-26 Arla Foods Amba Milk products with increased water binding
SE537951C2 (sv) * 2013-07-01 2015-12-01 Hero Ag Profylaktisk användning av modersmjölksersättning mot otit

Also Published As

Publication number Publication date
TW202110332A (zh) 2021-03-16
CN113873888A (zh) 2021-12-31
EP3975729A1 (en) 2022-04-06
SG11202111944SA (en) 2021-12-30
US20220211763A1 (en) 2022-07-07
WO2020239722A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
MX2021014518A (es) Composicion nutricional.
Marsh et al. Protein and vegetarian diets
Rossander et al. Absorption of iron from breakfast meals
Batiha et al. Dairy-derived and egg white proteins in enhancing immune system against COVID-19
HUP0303728A2 (hu) Tápanyagkészítmény
HK1118455A1 (en) Combination comprising at least one amino acid and a pkr inhibitor for use in the treatment of muscle loss
Lacomblez et al. A double‐blind, placebo‐controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis
SE8801732L (sv) Ny komposition
ATE508648T1 (de) Kalorien- und faserstoffreiche flüssige nahrungszusammensetzung für die darmgesundheit älterer patienten
WO2004093824A3 (en) Peri-operative and peri-procedure nutritional supplementation
HK1085927A1 (en) The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes
IS6178A (is) Samsetning sem nær yfir basískan svingómýelínasa af bakteríuuppruna til nota sem næringarfræðileg efnablanda, fæðubótarefni eða lyfjaafurð.
HK1039729A1 (en) Method for providing glutamine.
EP0308157A3 (en) Therapeutic applications of beta-adrenergic agonists
EP0388237A3 (en) Dietary product
MX2023004200A (es) Composicion nutricional.
Kimm et al. Secular trends in ischemic heart disease mortality: regional variation.
ES2036470A1 (es) Un producto alimenticio tipo hamburguesa
Kraehenbuehl et al. High fat versus high carbohydrate nutritional supplementation: a one year trial in stunted rural Gambian children
Pezza et al. Telogen effluvium treated with Serenoa repens supplement
BR0316135A (pt) Uso de um produto alimentìcio cozido
Metz, J. & Stein Iron deficiency anaemia in Bantu infants, and its association with Kwashiokor
JPS61104771A (ja) カルシウム豊富な栄養ふりかけ
Pastukhov et al. Local anesthesia and neuroleptanalgesia during surgery in thyrotoxicosis (Russian)
Lahey A method of palpating the lobes of the thyroid